ALFA Finder| Revenue growth | 20% YoY growth driven by patient volume and ARPP increases. |
|---|---|
| Margins | Improving; Operating EBITDA margin expanded 170 bps to 22.2%. |
| Demand visibility | High; 13% growth in patient volumes and 62% growth in MVT. |
| Management confidence | Strong; emphasizing disciplined execution and successful merger completion on schedule. |
Growth
Revenue grew 20% YoY to INR 2,597 Cr; Operating EBITDA surged 30% YoY to INR 576 Cr.
Outlook
Planned expansion of 4,179 beds by FY30 to reach 15,077 total capacity; aiming for 10-15% synergy-driven EBITDA uplift.
Risks
Indicative proforma numbers subject to audit adjustments and merger-related exceptional integration costs of INR 114.4 Cr.
Last quarter's promises, checked
Delivered
- Merger completion target Q1 FY27 → Completed on schedule (= BEAT)
- Operationalize 159-bed Whitefield block April 2026 → Commissioned (= BEAT)
- Operationalize 75-bed Ramesh Ongole April 2026 → Commissioned (= BEAT)
Partly delivered
- Target 2,500 beds over coming years → 159 beds added this quarter (= PARTIAL)
Investor Presentation filed with NSE, NSE: ASTERDM. Summary written with AI assistance from the document.
Aster DM Quality Care Ltd: key numbers
- Share price
- ₹724.20
- Market cap
- ₹63,127 Cr
- Revenue (annual)
- ₹4,643 Cr
- Net profit (annual)
- ₹388.1 Cr
- P/E (TTM)
- 134.1×Sector 54.5×
- Promoter holding
- 53.79%+13.40% QoQ
- FII holding
- 12.26%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Aster DM Quality Care Ltd
All →Aster DM Quality Care Adverse Business Impact
Aster DM Quality Care terminated its O&M and Medical Services agreements with DM Education and Research Foundation, ceasing related hospital operations. The Aster Wayanad hospital contributed 1.20% of turnover; no consideration was received.
Aster DM Quality Care Acquisition Worth ₹102.5 Cr
Aster DM will acquire Sri Sainatha Hospitals by converting a Rs 102.46 Crore loan into equity. The related-party deal completes within three months.
- Value
- ₹102.5 Cr
- Execution
- Within 3 months
Aster DM Quality Care Capital Structure Change
Aster DM approved converting a Rs 102.46 Crore subsidiary loan into equity shares. It also approved terminating DMERF operations and medical services agreements.
- Value
- ₹102.5 Cr
- Execution
- Within 3 months
Aster DM Quality Care Results Update
Aster DM Quality Care released a press release on its Q2 FY27 unaudited results, reporting revenue up 19% to Rs 2,829 crore. Normalised PAT rose 34% to Rs 281 crore.
Aster DM Quality Care Investor Presentation: Key Takeaways
Q2 FY27 revenue INR 2,829 Cr (+19% YoY), Op EBITDA INR 678 Cr (+25%), margin 24.0% (+111 bps), normalised PAT INR 281 Cr (+34%). Post-merger synergies and bed expansion to 15,070.
Aster DM Quality Care Q2 FY27 Results: Net Profit ₹322.4 Cr, Up 165.8% YoY
Aster DM Quality Care Ltd reported revenue from operations of ₹2,829 Cr (+136.3% YoY) and net profit of ₹322.4 Cr (+165.8% YoY) for Q2 FY27.
- Key figure
- Net profit ₹322.4 Cr · +165.8% YoY